Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering.
Elevation of Ser9 phosphorylation of GSK3β is required for HERV-W env-mediated BDNF signaling in human U251 cells.
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination.
Transplantation of Human Adipose-Derived Stem Cells Enhances Remyelination in Lysolecithin-Induced Focal Demyelination of Rat Spinal Cord.
Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS.
Fast Whole-Brain Three-dimensional Macromolecular Proton Fraction Mapping in Multiple Sclerosis.
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
Memory impairment in multiple sclerosis is due to a core deficit in initial learning.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Value of NMO-IgG determination at the time of presentation as CIS.
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (MOBILE)
Non-local robust detection of DTI white matter differences with small databases.
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
Information regarding Active Biotech's candidate drug laquinimod
Life-threatening asthma attack during prolonged fingolimod treatment: case report.
Epidemiology in multiple sclerosis: a pilgrim's progress.
Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model.
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
Pages
« first
‹ previous
…
177
178
179
180
181
182
183
184
185
…
next ›
last »